Metraipolis › archive › dc_7de374c040a0

Comprehensive safety analysis of the clinical spectrum of adverse events associated with immune checkpoint inhibitors based on FAERS — Europe PMC PMID:42148135

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42148135
DOI
10.3389/fimmu.2026.1823743
License (as archived)
solo-consultazione
Archived
2026-11-02T22:04:55.540Z
SHA-256 of the archived text
4f4c6045c29bde6cb9d2250c7f554221d97f5bc392ac5c7c5d6d972018b8e360
Stable URL of this page
https://metraipolis.com/documento/dc_7de374c040a0

How to cite

Comprehensive safety analysis of the clinical spectrum of adverse events associated with immune checkpoint inhibitors based on FAERS — Europe PMC PMID:42148135 — Europe PMC (en), https://europepmc.org/article/MED/42148135 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7de374c040a0 (Metraipolis archive dc_7de374c040a0, sha256 4f4c6045c29bde6cb9d2250c7f554221d97f5bc392ac5c7c5d6d972018b8e360)
BibTeX
@misc{dc7de374c040a0,
  title = {Comprehensive safety analysis of the clinical spectrum of adverse events associated with immune checkpoint inhibitors based on FAERS — Europe PMC PMID:42148135},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42148135},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7de374c040a0; sha256 4f4c6045c29bde6cb9d2250c7f554221d97f5bc392ac5c7c5d6d972018b8e360},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42148135. Agents can read the archived copy with the MCP tool read_document.